SchatzA, BugieE, WaksmanSA. Streptomycin, a substance exhibiting antibiotic activity against gram-positive and gram-negative bacteria. Proc Soc Exp Biol Med1944; 55:66–9.
2.
HinshawHC, FeldmanWH. Streptomycin in treatment of clinical tuberculosis: A preliminary report. Proc Mayo Clinic1945; 20:313–18.
3.
CorradoAP. Respiratory depression due to antibiotics: calcium in treatment. J Intern Anest Res Soc1963; 42:1–5.
4.
GordonS, SensonJ, FacklamR, NNIS Enterococcal Study Group: A multicenter study of the epidemiology of enterococcal infections (abstract). Program Abstr Intersci Co Antimicrob Agents Chemother1989; 29:233.
5.
ChiewYF, LimSW, KuahBG, Prevalence in Singapore of enterococci with high-level resistance to aminoglycosides and comparison of three methods for their detection. J Infect1993; 27:125–31.
6.
EdsonRS, TerrellCL. The Aminoglycosides. Proc Mayo Clinic1991; 66:1158–64.
7.
LuYF. Cause of 611 deaf mutes in schools for deaf children in Shanghai. Shanghai Med J1987; 10:159.
8.
WhiteGLJr., HenthorneBH, BarnesSE, Tuberculosis: A health education imperative returns. J Community Health1995; 20:29–57.
9.
WheltonA.Therapeutic initiatives for the avoidance of aminoglycoside toxicity. J Clin Pharmacol1985; 25:67–81.
10.
FeeWE. Aminoglycoside ototoxicity in the human. Laryngoscope1980; 40:1–19.
11.
GatellJM, San MiguelJG, ZamoraL, Comparison of the nephrotoxicity and auditory toxicity of tobramycin and amikacin. Antimicrob Agents Chemother1983; 23:897–901.
12.
GatellJM, FerranF, AraujoV, Univariate and multivariate analyses of risk factors predisposing to auditory toxicity in patients receiving aminoglycosides. Antimicrob Agents Chemother1987; 31:1383–7.
13.
BurtonME, BraterDC, ChenPS, A Bayesian feedback method of aminoglycoside dosing. Clin Pharmacol Ther1985; 37:349–57.
14.
RodvoldKA, BlumRA. Predictive performance of Sawchuk-Zaske and Bayesian dosing methods for tobramycin. J Clin Pharmacol1987; 27:419–24.
15.
BeggEJ, BarclayML, DuffullSB. A suggested approach to once-daily aminoglycoside dosing. Br J Clin Pharmacol1995; 39:605–9.
16.
PrazmaJ, GarrisonHG, WillifordSK, Alteration of aminoglycoside antibiotic ototoxicity: Effect of semistarvation. Ann Otol Rhinol Laryngol1983; 92:178–82.
17.
LautermannJ, McLarenJ, SchachtJ.Glutathione protection against gentamicin ototoxicity depends on nutritional status. Hear Res1995; 86:15–24.
18.
GaretzSL, AltschulerRA, SchachtJ.Attenuation of gentamicin ototoxicity by glutathione in the guinea pig in vivo. Hear Res1994; 77:81–7.
19.
FederspilP.Antibiotikaschäden des Ohres. Leipzig, Barth, 1979.
20.
PrezantTR, ShohatM, JaberL, Biochemical characterization of a pedigree with mitochondrially inherited deafness. Am J Med Genet1992; 44:465–72.
21.
ForgeA.Outer hair cell loss and supporting cell expenasion following chronic gentamicin treatment. Hear Res1985; 19:171–82.
22.
ForgeA, FradisM.Structural abnormalities in the stria vascularis following chronic gentamicin treatment. Hear Res1985; 20:233–44.
WarcholME, LambertPR, GoldsteinBJ, Regenerative proliferation in inner ear sensory epithelia from adult guinea pigs and humans. Science1993; 259:1619–22.
25.
SchachtJ.Biochemical basis of aminoglycoside ototoxicity. Otolaryngol Clin North Am1993; 26:845–56.
26.
GaretzS, SchachtJ.Ototoxicity: Of mice and men, in FayRR, PopperAN (eds): Handbook of Auditory Research, Vol. VI: Clinical Aspects of Hearing (VanDeWaterTR, ed). New York, Springer-Verlag, in press.
27.
TranBaHuyP, BernardP, SchachtJ.Kinetics of gentamicin uptake and release in the rat. Comparison of inner ear tissues and fluids with other organs. J Clin Invest1986; 77:1492–1500.
28.
DulonD, AranJM, ZajicG, Comparative uptake of gentamicin, netilmicin, and amikacin in the guinea pig cochlea and vestibule. Antimicrob Agents Chemother1986; 30:96–100.
29.
AranJM, ErreJP, GuilhaumeA, The comparative ototoxicities of gentamicin, tobramycin and dibekacin in the guinea pig. A functional and morphological cochlear and vestibular study. Acta Otolaryngol Suppl (Stockh)1982; 390:1–30.
30.
HenleyCM, SchachtJ.Pharmacokinetics of aminoglycoside antibiotics in blood, inner-ear fluids and tissues and their relationship to ototoxicity. Audiology1988; 27:137–46.
31.
SchachtJ.Isolation of an aminoglycoside receptor from guinea pig inner ear tissues and kidney. Arch Otorhinolaryngol1979; 224:129–34.
32.
RichardsonGP, RussellIJ. Cochlear cultures as a model system for studying aminoglycoside induced ototoxicity. Hear Res1991; 53:293–311.
ZennerHP, GitterA, ZimmermannU, The isolated living hair cell — a new model to investigate hearing function. Laryngol Rhinol Otol1985; 64:642–7.
35.
DulonD, ZajicG, AranJM, Aminoglycoside antibiotics impair calcium entry but not viability and motility in isolated cochlear outer hair cells. J Neurosci Res1989; 24:338–46.
36.
WilliamsSE, ZennerHP, SchachtJ.Three molecular steps of aminoglycoside ototoxicity demonstrated in outer hair cells. Hear Res1987; 30:11–8.
37.
HuangMY, SchachtJ.Formation of a cytotoxic metabolite from gentamicin by liver. Biochem Pharmacol1990; 40: R11–4.
38.
CrannSA, HuangMY, McLarenJD, Formation of a toxic metabolite from gentamicin by a hepatic cytosolic fraction. Biochem Pharmacol1992; 43:1835–9.
39.
SchentagJJ, JuskoWJ. Renal clearance and tissue accumulation of gentamicin. Clin Pharmacol Ther1977; 22:364–70.
40.
GaretzS, SchachtJ.Sulfhydryl compounds reduce gentamicin-induced outer hair cell damage in vitro. Assoc Res Otolarynogl1992; 15:110.
41.
GaretzSL, RheeDJ, SchachtJ.Sulfhydryl compounds and antioxidants inhibit cytotoxicity to outer hair cells of a gentamicin metabolite in vitro. Hear Res1994; 77:75–80.
42.
ZennerHP, KeinerS, ZimmermanU.Specific glutathione-SH inhibition of toxic effects of metabolized gentamicin on isolated guinea pig hair cells. Eur Arch Otorhinolaryngol1994; 251:84–90.
43.
PiersonMG, MillerAG. Prophylaxis of kanamycin-induced ototoxicity by a radioprotectant. Hear Res1981; 7:79–87.
44.
BockGR, YatesGK, MillerJJ, Effects of N-acetylcysteine on kanamycin ototoxicity in the guinea pig. Hear Res1983; 9:255–62.
45.
DarrouzetMJ. Attempt to protect the organ of Corti against the ototoxicity of antibiotics. Acta Otolaryngol (Stockh)1967; 63 (Suppl):49–64.
46.
GuoLH, HillHA, HopperDJ, Direct voltammetry of the Chromatium vinosum enzyme, sulfide:xytochrome coxidoreductase (flavocytochrome c552). J Biol Chem1990; 265:1958–63.
47.
PriuskaEM, SchachtJ.Formation of free radicals by gentamicin and iron and evidence for an iron/gentamicin complex. Biochemical Pharmacology1995; 50:1749–52.
48.
WangH, PriuskaEM, SchachtJ.The iron embrace: Exposing the secret activities of gentamicin. Assoc Res Otolaryngol1996; 19:29.
49.
ShaSH, SchachtJ.Amplification of free radicals by gentamicin in biological systems. Assoc Res Otolaryngol1996; 19:30.
50.
SongB-B, SchachtJ.Variable efficacy of radical scavengers and iron chelators to attenuate gentamicin ototoxicity in guinea pig in vivo. Hear Res1996; 94:87–93.
51.
KannoH, RybakLP, WhitworthC.The cochlear ototoxicity due to deferoxamine mesylate. Assoc Res Otolaryngol1995; 18:76.
52.
van AsbeckBS, MarcelisJH, van KatsJH, Synergy between the iron chelator deferoxamine and the antimicrobial agents gentamicin, chloramphenicol, cefalothin, cefotiam and cefsulodin. Eur J Clin Microbiol1983; 2:432–8.